Patel, Chirag H.
Leone, Robert D.
Horton, Maureen R.
Powell, Jonathan D. https://orcid.org/0000-0002-0850-2852
Article History
Accepted: 19 June 2019
First Online: 30 July 2019
Competing interests
: J.D.P. has equity in Dracen, Sitryx (<5%) and Corvus (<5%); has consulted for Dracen, as well as for Sitryx, Corvus, Aeonian, Sigma and Quadriga; has received sponsored research money from Abbvie, Quadriga, Dracen, Bluebird and Bristol-Myers Squibb in the last year; and has patents licensed by Dracen. The other authors declare no competing interests.